Jump to content
RemedySpot.com
Sign in to follow this  
Guest guest

Race, insulin resistance and hepatic steatosis in chronic hepatitis C

Rate this topic

Recommended Posts

Guest guest

Hepatology. 2007 Jan;45(1):80-7.

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH,

Wahed AS.

University of Michigan, Ann Arbor, MI.

Hepatic steatosis is common in chronic hepatitis C and has been linked to

concurrent obesity, insulin resistance, diabetes, disease severity, and poor

response to therapy. Racial differences in rates of obesity and diabetes may

contribute to racial differences in hepatic steatosis and treatment

response. The aim of the present study was to compare hepatic steatosis and

its associations between African American (AA) and Caucasian American (CA)

patients with chronic hepatitis C, genotype 1, participating in a

prospective study of peginterferon and ribavirin therapy. Liver biopsy

results were available from 194 AA patients and 205 CA patients. The 2

groups were compared for anthropometric, clinical, and biochemical features

and insulin resistance estimated by the homeostasis model assessment index

(HOMA-IR). Sixty-one percent of the AA patients and 65% of the CA patients

had hepatic steatosis (P = 0.38). In univariable analysis, steatosis was

associated with HOMA-IR, body mass index, waist circumference, serum

triglycerides, aminotransferase level, and histological scores for

inflammation and fibrosis. After adjusting for these features, AA patients

had a lower risk of steatosis than did CA patients (OR 0.54, 95% CI

0.32-0.91, P = 0.02). Insulin resistance but not steatosis was associated

with a lower rate of sustained virological response when adjusted for known

factors that predict response (relative risk 0.87, 95% CI 0.77-0.99, P =

0.028). Conclusion: After adjusting for the higher prevalence of features

associated with hepatic steatosis, AA patients had a lower prevalence of

hepatic steatosis than did CA patients with chronic hepatitis C, genotype 1.

Insulin resistance but not steatosis was independently associated with lower

sustained virological response. (HEPATOLOGY 2006;45:80-87.).

PMID: 17187406 [PubMed - in process]

_________________________________________________________________

Type your favorite song.  Get a customized station.  Try MSN Radio powered

by Pandora. http://radio.msn.com/?icid=T002MSN03A07001

Share this post


Link to post
Share on other sites
Guest guest

Hepatology. 2007 Jan;45(1):80-7.

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH,

Wahed AS.

University of Michigan, Ann Arbor, MI.

Hepatic steatosis is common in chronic hepatitis C and has been linked to

concurrent obesity, insulin resistance, diabetes, disease severity, and poor

response to therapy. Racial differences in rates of obesity and diabetes may

contribute to racial differences in hepatic steatosis and treatment

response. The aim of the present study was to compare hepatic steatosis and

its associations between African American (AA) and Caucasian American (CA)

patients with chronic hepatitis C, genotype 1, participating in a

prospective study of peginterferon and ribavirin therapy. Liver biopsy

results were available from 194 AA patients and 205 CA patients. The 2

groups were compared for anthropometric, clinical, and biochemical features

and insulin resistance estimated by the homeostasis model assessment index

(HOMA-IR). Sixty-one percent of the AA patients and 65% of the CA patients

had hepatic steatosis (P = 0.38). In univariable analysis, steatosis was

associated with HOMA-IR, body mass index, waist circumference, serum

triglycerides, aminotransferase level, and histological scores for

inflammation and fibrosis. After adjusting for these features, AA patients

had a lower risk of steatosis than did CA patients (OR 0.54, 95% CI

0.32-0.91, P = 0.02). Insulin resistance but not steatosis was associated

with a lower rate of sustained virological response when adjusted for known

factors that predict response (relative risk 0.87, 95% CI 0.77-0.99, P =

0.028). Conclusion: After adjusting for the higher prevalence of features

associated with hepatic steatosis, AA patients had a lower prevalence of

hepatic steatosis than did CA patients with chronic hepatitis C, genotype 1.

Insulin resistance but not steatosis was independently associated with lower

sustained virological response. (HEPATOLOGY 2006;45:80-87.).

PMID: 17187406 [PubMed - in process]

_________________________________________________________________

Type your favorite song.  Get a customized station.  Try MSN Radio powered

by Pandora. http://radio.msn.com/?icid=T002MSN03A07001

Share this post


Link to post
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
Sign in to follow this  

×
×
  • Create New...